Cargando…
Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892251/ https://www.ncbi.nlm.nih.gov/pubmed/36736492 http://dx.doi.org/10.1016/j.jinf.2023.01.038 |
| _version_ | 1784881301577269248 |
|---|---|
| author | Amano, Masayuki Ichikawa, Yasuko Uemura, Yukari Matsumoto, Shota Maeda, Kenji Matsushita, Shuzo Shimada, Shinya Mitsuya, Hiroaki |
| author_facet | Amano, Masayuki Ichikawa, Yasuko Uemura, Yukari Matsumoto, Shota Maeda, Kenji Matsushita, Shuzo Shimada, Shinya Mitsuya, Hiroaki |
| author_sort | Amano, Masayuki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9892251 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98922512023-02-02 Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines Amano, Masayuki Ichikawa, Yasuko Uemura, Yukari Matsumoto, Shota Maeda, Kenji Matsushita, Shuzo Shimada, Shinya Mitsuya, Hiroaki J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2023-05 2023-02-02 /pmc/articles/PMC9892251/ /pubmed/36736492 http://dx.doi.org/10.1016/j.jinf.2023.01.038 Text en © 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Amano, Masayuki Ichikawa, Yasuko Uemura, Yukari Matsumoto, Shota Maeda, Kenji Matsushita, Shuzo Shimada, Shinya Mitsuya, Hiroaki Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines |
| title | Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines |
| title_full | Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines |
| title_fullStr | Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines |
| title_full_unstemmed | Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines |
| title_short | Comparison of neutralization activity against Omicron BA.2/BA.5 in sera from HCWs receiving heterologous/homologous COVID-19 vaccines |
| title_sort | comparison of neutralization activity against omicron ba.2/ba.5 in sera from hcws receiving heterologous/homologous covid-19 vaccines |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892251/ https://www.ncbi.nlm.nih.gov/pubmed/36736492 http://dx.doi.org/10.1016/j.jinf.2023.01.038 |
| work_keys_str_mv | AT amanomasayuki comparisonofneutralizationactivityagainstomicronba2ba5inserafromhcwsreceivingheterologoushomologouscovid19vaccines AT ichikawayasuko comparisonofneutralizationactivityagainstomicronba2ba5inserafromhcwsreceivingheterologoushomologouscovid19vaccines AT uemurayukari comparisonofneutralizationactivityagainstomicronba2ba5inserafromhcwsreceivingheterologoushomologouscovid19vaccines AT matsumotoshota comparisonofneutralizationactivityagainstomicronba2ba5inserafromhcwsreceivingheterologoushomologouscovid19vaccines AT maedakenji comparisonofneutralizationactivityagainstomicronba2ba5inserafromhcwsreceivingheterologoushomologouscovid19vaccines AT matsushitashuzo comparisonofneutralizationactivityagainstomicronba2ba5inserafromhcwsreceivingheterologoushomologouscovid19vaccines AT shimadashinya comparisonofneutralizationactivityagainstomicronba2ba5inserafromhcwsreceivingheterologoushomologouscovid19vaccines AT mitsuyahiroaki comparisonofneutralizationactivityagainstomicronba2ba5inserafromhcwsreceivingheterologoushomologouscovid19vaccines |